Page last updated: 2024-08-23

raloxifene hydrochloride and Hot Flashes

raloxifene hydrochloride has been researched along with Hot Flashes in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (7.50)	18.2507
2000's	26 (65.00)	29.6817
2010's	11 (27.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conner, EA; Pinkerton, JV	1
Chines, AA; Gallagher, JC; Mirkin, S; Shi, H	1
Pinkerton, JV; Thomas, S	1
Silverman, S	1
Chandler, J; Denker, AE; Gottesdiener, K; He, W; Lazarus, N; Rosenberg, E; Simon, JA; Wagner, JA	1
Ichikawa, S; Kanda, T; Kasama, S; Kumakura, H; Kurabayashi, M; Murakami, M; Sumino, H; Takahashi, T; Takayama, Y	1
Capp, E; de Freitas, FM; Edelweiss, MI; Valiati, B; Wender, MC	1
Bachmann, G; Constantine, GD; Crosby, U; Feldman, RA; Ronkin, S	1
Alam, J; Cox, DA; Dowsett, SA; Kendler, DL; Palacios, S; Stock, J; Zanchetta, J	1
Cecchini, RS; Costantino, JP; Cronin, WM; Ford, LG; Runowicz, CD; Vogel, VG; Wickerham, DL; Wolmark, N	1
Carneiro, AL; de Cassia de Maio Dardes, R; Haidar, MA	1
Eyster, KM; Hansen, KA	1
Hadji, P	1
Colao, A; Lombardi, G; Nappi, C; Orio, F; Palomba, S; Panici, PL; Russo, T; Tauchmanovà, L; Zullo, F; Zupi, E	1
Ciaccia, AV; Gordon, S; Plouffe, L; Rosen, AS; Siddhanti, S; Walsh, BW	1
Rollins, G	1
Jordan, VC	1
Cianci, A; De Leo, V; Farina, M; La Marca, A; Morgante, G; Petraglia, F	1
Almeida, MJ; Farias, ML; Gomez, G; Kayath, MJ; Luebbert, H; Mönnig, E; Nickelsen, T; Palacios, S; Quail, DC; Turbi, C; Yabur, JA	1
Morii, H	1
Shintani, M	1
Aguas, F; Aldrighi, JM; Bosio-Le Goux, B; Garrido, L; Graebe, A; Kosian, K; Levy-Frebault, J; Nickelsen, T; Niño, AJ; Quail, DC; Saráchaga, M	1
DeGregorio, MW; Erkkola, R; Härkönen, P; Kivinen, S; Komi, J; Lankinen, KS; Tuimala, R; Vihko, K; Vihtamäki, T; Voipio, S; Ylikorkala, O	1
Deng, W; He, W	1
Vastag, B	1
Lee, B; Lorraine, J	1
Nakamura, T	1
Bjarnason, NH; Christiansen, C; Delmas, PD; Draper, M; Huster, WJ; Mitlak, BH; Ravoux, AC; Shah, AS	1
Davies, GC; Huster, WJ; Lakshmanan, M; Lu, Y; Plouffe, L	1
Agnusdei, D; Iori, N	1
Cohen, FJ; Lu, Y	1
Cuzick, J	1
Barrett-Connor, E; Cox, DA; Grady, D; Krueger, K; Nickelsen, T; Sarkar, S; Yaffe, K	1
Berendsen, HH; Kloosterboer, HJ; Weekers, AH	1
Gapstur, S; Jordan, VC; Morrow, M	1
Cauley, JA; Cummings, SR; Duong, T; Kenyon, E; Krueger, KA; Whitehead, M	1
Barrett-Connor, E	1
Grady, D	1
Blau, R; Lower, EE; Rohatgi, N	1

Reviews

11 review(s) available for raloxifene hydrochloride and Hot Flashes

Article	Year
Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators. Climacteric : the journal of the International Menopause Society, 2019, Volume: 22, Issue:2 Topics: Adult; Aged; Atrophy; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina	2019
Use of SERMs for treatment in postmenopausal women. The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Breast Neoplasms; Clinical Trials as Topic; Dyspareunia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Toremifene	2014
Estrogens plus raloxifene on endometrial safety and menopausal symptoms--semisystematic review. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:7 Topics: Drug Therapy, Combination; Endometrium; Estrogens; Female; Hot Flashes; Humans; Hyperhidrosis; Postmenopause; Quality of Life; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vagina	2012
The evolution of selective estrogen receptor modulators in osteoporosis therapy. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Endometrial Neoplasms; Female; Fractures, Bone; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spinal Fractures; Tetrahydronaphthalenes	2012
Selective estrogen receptor modulation: concept and consequences in cancer. Cancer cell, 2004, Volume: 5, Issue:3 Topics: Apoptosis; Breast Neoplasms; Dimerization; Drug Resistance; Endometrial Neoplasms; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Osteoporosis; Protein Binding; Protein Conformation; Protein Interaction Mapping; Raloxifene Hydrochloride; Receptors, Estrogen; Signal Transduction; Tamoxifen	2004
[Safety profile of raloxifene]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Asian People; Clinical Trials as Topic; Female; Hot Flashes; Humans; Leg; Muscle Cramp; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Venous Thrombosis; White People	2004
[Which is the better choice, estrogen or SERMs in postmenopausal women?]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hip Fractures; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Uterine Hemorrhage	2004
[Adverse events of drugs for the treatment of osteoporosis]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Cholecalciferol; Diphosphonates; Gastrointestinal Diseases; Hot Flashes; Humans; Hypercalcemia; Jaw Diseases; Macular Edema; Necrosis; Osteoporosis; Raloxifene Hydrochloride; Venous Thrombosis	2007
Tolerability profile of SERMs. Journal of endocrinological investigation, 1999, Volume: 22, Issue:8 Topics: Animals; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Venous Thrombosis	1999
Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Journal of the National Cancer Institute, 2001, Oct-03, Volume: 93, Issue:19 Topics: Adult; Aged; Bone and Bones; Breast; Breast Neoplasms; Cardiovascular System; Cinnamates; Clinical Trials as Topic; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Heart; Hot Flashes; Humans; Middle Aged; Models, Biological; Organ Specificity; Osteoporosis; Postmenopause; Premenopause; Prospective Studies; Protein Structure, Tertiary; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk; Risk Assessment; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thrombophilia; Transcription, Genetic	2001
Raloxifene: risks and benefits. Annals of the New York Academy of Sciences, 2001, Volume: 949 Topics: Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Hot Flashes; Humans; Morbidity; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Thromboembolism	2001

Trials

15 trial(s) available for raloxifene hydrochloride and Hot Flashes

Article	Year
Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogens. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:11 Topics: Bone Density; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Quality of Life; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Severity of Illness Index; Treatment Outcome	2013
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:9 Topics: Adult; Double-Blind Method; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medical Records; Menopause; Middle Aged; Paroxetine; Raloxifene Hydrochloride; Reproducibility of Results; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2014
Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial. Maturitas, 2009, Jan-20, Volume: 62, Issue:1 Topics: Administration, Cutaneous; Aged; Drug Therapy, Combination; Endometrium; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Patient Satisfaction; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2009
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5 Topics: Bone and Bones; Bone Density Conservation Agents; Female; Hot Flashes; Humans; Indoles; Lipids; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2011
Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:3 Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Double-Blind Method; Female; Femur Neck; Hip Joint; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Thiophenes; Treatment Outcome	2012
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:12 Topics: Delayed-Action Preparations; Female; Hot Flashes; Humans; Leiomyoma; Leuprolide; Menorrhagia; Pain; Patient Dropouts; Placebos; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Neoplasms	2002
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms. Obstetrics and gynecology, 2004, Volume: 103, Issue:2 Topics: Administration, Oral; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Postmenopause; Probability; Progestins; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Vasomotor System	2004
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:4 Topics: Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Female; Hot Flashes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prolactin; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sulpiride; Treatment Outcome	2004
Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate. American journal of obstetrics and gynecology, 2004, Volume: 191, Issue:1 Topics: Aged; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2004
Predictors of hot flushes in postmenopausal women who receive raloxifene therapy. American journal of obstetrics and gynecology, 2004, Volume: 191, Issue:6 Topics: Administration, Oral; Aged; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hot Flashes; Humans; Logistic Models; Middle Aged; Postmenopause; Probability; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Treatment Outcome	2004
Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women. Menopause (New York, N.Y.), 2005, Volume: 12, Issue:2 Topics: Double-Blind Method; Drug Administration Schedule; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Lipids; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Tamoxifen; Treatment Outcome; Uterus; Vagina	2005
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. The New England journal of medicine, 1997, Dec-04, Volume: 337, Issue:23 Topics: Bone Density; Cholesterol; Cholesterol, LDL; Double-Blind Method; Endometrium; Estrogen Antagonists; Female; Hip Joint; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Raloxifene Hydrochloride	1997
Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstetrics and gynecology, 1999, Volume: 93, Issue:4 Topics: Adult; Aged; Breast Diseases; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Middle Aged; Pain; Piperidines; Postmenopause; Raloxifene Hydrochloride; Uterine Hemorrhage	1999
Cognitive function in postmenopausal women treated with raloxifene. The New England journal of medicine, 2001, Apr-19, Volume: 344, Issue:16 Topics: Aged; Cognition; Cognition Disorders; Female; Hot Flashes; Humans; Memory; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2001
Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA, 2002, Jan-09, Volume: 287, Issue:2 Topics: Aged; Breast Neoplasms; Estradiol; Female; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Venous Thrombosis	2002

Other Studies

14 other study(ies) available for raloxifene hydrochloride and Hot Flashes

Article	Year
Individualizing osteoporosis medications. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:3 Topics: Absorptiometry, Photon; Administration, Intranasal; Aged; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium, Dietary; Denosumab; Diphosphonates; Female; Hip Fractures; Hot Flashes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Precision Medicine; Raloxifene Hydrochloride; Risk Factors; Vitamin D	2014
Effects of raloxifene and hormone replacement therapy on forearm skin elasticity in postmenopausal women. Maturitas, 2009, Jan-20, Volume: 62, Issue:1 Topics: Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Case-Control Studies; Elasticity; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Skin	2009
Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR). American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:6 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Estrogen Antagonists; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Leiomyoma; Middle Aged; Ovarian Cysts; Polyps; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms; Vaginal Discharge	2011
What happened to WHI: menopausal hormonal therapy in 2012. Clinical obstetrics and gynecology, 2012, Volume: 55, Issue:3 Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina	2012
ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists: Number 39, October 2002. Selective estrogen receptor modulators. Obstetrics and gynecology, 2002, Volume: 100, Issue:4 Topics: Bone Resorption; Breast Neoplasms; Cardiovascular Diseases; Endometrium; Female; Genitalia, Female; Hot Flashes; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Thromboembolism	2002
Hormone alternative doesn't worsen vasomotor symptoms or impact urinary incontinence in post-menopausal women. Report on medical guidelines & outcomes research, 2004, Mar-05, Volume: 15, Issue:5 Topics: Dose-Response Relationship, Drug; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Hyperhidrosis; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Urinary Incontinence; Vasomotor System	2004
Identifying methodologies in the assessment of treatment effects on the repeated occurrences of hot flashes in postmenopausal women. Clinical trials (London, England), 2005, Volume: 2, Issue:6 Topics: Analysis of Variance; Clinical Trials as Topic; Computer Simulation; Female; Hot Flashes; Humans; Logistic Models; Markov Chains; Models, Statistical; Raloxifene Hydrochloride; Recurrence; Research Design; Selective Estrogen Receptor Modulators; Severity of Illness Index; Time Factors; Treatment Outcome	2005
Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs. Journal of the National Cancer Institute, 2006, Jun-07, Volume: 98, Issue:11 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cataract; Contraindications; Controlled Clinical Trials as Topic; Drug Approval; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Thromboembolism; Treatment Outcome; United States; United States Food and Drug Administration; Uterine Neoplasms	2006
A Canadian observational study of the optimal method of transition from postmenopausal hormone therapy to raloxifene. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2006, Volume: 28, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Patient Satisfaction; Postmenopause; Quality of Life; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sweating	2006
Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas, 2000, Jan-15, Volume: 34, Issue:1 Topics: Adult; Double-Blind Method; Estrogen Antagonists; Female; Hot Flashes; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Severity of Illness Index; Time Factors	2000
A brief review of the current breast cancer prevention trials and proposals for future trials. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:10 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Endometrial Neoplasms; Female; Hot Flashes; Humans; Menstruation Disturbances; Meta-Analysis as Topic; Middle Aged; Raloxifene Hydrochloride; Risk Factors; Tamoxifen	2000
Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1 Topics: Adrenergic alpha-Agonists; Anabolic Agents; Animals; Body Temperature; Clonidine; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Hot Flashes; Humans; Motor Activity; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tail	2001
A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA, 2002, Apr-24, Volume: 287, Issue:16 Topics: Alendronate; Breast Neoplasms; Contraindications; Coronary Disease; Decision Making; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrocystic Breast Disease; Hot Flashes; Humans; Hysterectomy; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Venous Thrombosis	2002
Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. Journal of women's health & gender-based medicine, 2002, Volume: 11, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Estrogen Antagonists; Female; Hot Flashes; Humans; Libido; Middle Aged; Neoplasms, Hormone-Dependent; Raloxifene Hydrochloride; Retrospective Studies; Selective Estrogen Receptor Modulators; Surveys and Questionnaires; Tamoxifen; Time Factors; Vaginal Discharge; Weight Gain	2002